<DOC>
	<DOCNO>NCT02658344</DOCNO>
	<brief_summary>The purpose study investigate efficacy safety autologous transplantation Adipose Tissue derive Mesenchymal stem cell ( MSCs ) patient Knee Osteoarthritis .</brief_summary>
	<brief_title>Clinical Trial Evaluate Efficacy Safety JOINTSTEM Patients With Degenerative Arthritis</brief_title>
	<detailed_description>JOINTSTEM OA treatment use autologous adipose-derived mesenchymal stem cell . As use allogenic tissue incubate without additional genetic modification mechanical chemical modification differentiation , classify 'autologous cell therapy ' completely free immunologic rejection . It primarily aim improve pain joint function , secondary , regenerate cartilage . The intra-articular injection JOINTSTEM expect stimulate regeneration growth cartilage , innovatively improve pain joint function cartilage regeneration within six month . The subject therapy regenerative patient K &amp; L grade 2~4 age 18 old . JOINTSTEM expect used patient significantly damage cartilage due cartilage regeneration ability , addition improvement pain joint performance . A ; sp . Patients already undergone knee arthroplasty delay additional surgery use JOINTSTEM . For dose still cartilage , arthroplasty immediate treatment option , osteoporosis patient undergo arthroplasty due advance age receive JOINTSTEM .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>1 . Age 18 old , male female 2 . Patients must consent write participate study sign date informed consent document 3 . Diagnosis osteoarthritis ACR osteoarthritis knee 4 . Diagnosis osteoarthritis radiographic criterion Kellgren Lawrence grade 24 5 . More Grade 4 ( 0~10 point numeric scale ) pain least 12 week 6 . Diagnosis osteoarthritis class Ⅰ~Ⅲ ACR ( American College Rheumatology Criteria ) Global functional criterion 7 . Patient agree contraception 1 . Preparing Pregnancy Pregnant woman lactate mother . 2 . Patients Body Mass Index ( BMI ) &gt; 35 . 3 . Patients disease include : Septic arthritis , Rheumatoid Inflammatory joint disease , Crystalline disease ( gout pseudogout ) , Paget disease , Articular fracture , Ochronosis , Acromegaly , Hemochromatosis , Wilson 's disease , Osteochondromatosis , Hereditary disorder 4 . Patients serious condition internal medicine disease 5 . Patients positive human immunodeficiency ( HIV ) , hepatitis B ( HBV ) , hepatitis C ( HCV ) , syphilis screen indicative current pas infection . 6 . Patient behavioral disorder , cognitive disorder chronic mental symptom 7 . Patient significant neurologic psychiatric disorder 8 . Patients alcohol , drug abuse history 9 . Patients participate clinical trial within 12 week prior study . 10 . Patients receive drug intraarticular injection treatment within 2 month prior enrollment . 11 . Patients experience knee joint cartilage stem cell therapy 12 . Patients principal investigator considers inappropriate clinical trial due reason list 13 . Patients penicillin hypersensitivity reaction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Stem cell</keyword>
	<keyword>adipose tissue derive mesenchymal stem cell</keyword>
	<keyword>osteoarthritis</keyword>
	<keyword>degenerative arthritis</keyword>
	<keyword>biostar</keyword>
	<keyword>Rbio</keyword>
</DOC>